Roche to invest $50 billion in U.S. as pharma tariff threat lingers
stocks, news, data and earnings
Harvard demands the Trump administration for freezing funds • International • Forbes Mexico
Tariff turmoil may have killed the tech M&A market’s comeback
Credit Card Delinquencies Have Hit a Record High